Results 21 to 30 of about 364,439 (227)

Use of a rapid digital microfluidics-powered immunoassay for assessing measles and rubella infection and immunity in outbreak settings in the Democratic Republic of the Congo.

PLoS ONE, 2022
The Democratic Republic of the Congo (DRC) has a high measles incidence despite elimination efforts and has yet to introduce rubella vaccine. We evaluated the performance of a prototype rapid digital microfluidics powered (DMF) enzyme-linked immunoassay (
Alaine K Knipes, Aimee Summers, Alexandros A Sklavounos, Julian Lamanna, Richard P S de Campos, Tanya Narahari, Christopher Dixon, Ryan Fobel, Yassa D Ndjakani, Leopold Lubula, Alain Magazani, Jean Jacques Muyembe, Yvonne Lay, Elizabeth Pukuta, Diane Waku-Kouomou, Lijuan Hao, Jolie Kasongo Kayembe, Christian Fobel, Joshua Dahmer, Adam Lee, Man Ho, Jose Gilberto Camacho Valenzuela, Darius G Rackus, Roger Shih, Brendon Seale, Ann Chang, Gilson Paluku, Paul A Rota, Aaron R Wheeler, Heather M Scobie   +29 more
doaj   +1 more source

Factors associated with uptake of measles, mumps, and rubella vaccine (MMR) and use of single antigen vaccines in a contemporary UK cohort: prospective cohort study [PDF]

, 2008
Objectives To estimate uptake of the combined measles, mumps, and rubella vaccine (MMR) and single antigen vaccines and explore factors associated with uptake and reasons for not using MMR.Design Nationally representative cohort study.Setting Children ...
Law, C, Pearce, Anna, Elliman, David, Law, Catherine, Bedford, Helen, Bedford, H, Pearce, A, Millennium Cohort Study Child Hlth, Cole, Tim J., Elliman, D, Cole, TJ   +10 more
core   +1 more source

Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: Population study [PDF]

, 2002
OBJECTIVES: To investigate whether measles, mumps, and rubella (MMR) vaccination is associated with bowel problems and developmental regression in children with autism, looking for evidence of a "new variant" form of autism. DESIGN: Population study with
Andrews, N, Stowe, J, Andrews, Nick, Stowe, Julia, Miller, E, Miller, Elizabeth, Simmons, Andrea, Lingam, R, Simmons, A, Taylor, Brent, Taylor, B, Lingam, Raghu   +11 more
core   +1 more source

Effectiveness of interventions to improve the uptake of immunisation in primary care, with specific focus on Mumps, Measles and Rubella (MMR) [PDF]

, 2009
Background: There has been a decade of MMR vaccine uptake which is below the threshold for herd immunity for measles and large numbers of children are unprotected. The number of measles cases in England is now rising (DH, 2008).
Morrell, Jane, Topping, Annie, McCluskey, Serena, Lui, Steve   +3 more
core   +4 more sources

Childhood MMR Vaccination Effectiveness Against Rubella: A Longitudinal Cohort Study

Global Pediatric Health, 2022
The vaccine effectiveness (VE) of childhood measles-mumps-rubella (MMR) vaccine to reduce childhood rubella infections in the US during the 1990s/2000s was undertaken in a retrospective longitudinal cohort study.
David A. Geier BA, Mark R. Geier MD, PhD, FACE   +1 more
doaj   +1 more source

Modeling the dynamics of rubella disease with vertical transmission

Heliyon, 2022
Rubella is a highly contagious and serious human disease caused by the rubella virus. It affects everyone around the world, but it is especially common in pregnant women and children. In particular, when pregnant women are infected with the rubella virus,
Getachew Teshome Tilahun, Tariku Merga Tolasa, Getinet Alemayehu Wole   +2 more
doaj   +1 more source

Safety and immunological effectiveness of the domestic combined trivaccine for the prevention of measles, rubella and mumps Vaktrivir^® in children 12 months and 6 years of age (results of a simple blind multicenter comparative randomized clinical trial)

Эпидемиология и вакцинопрофилактика, 2021
Relevanc. Measles, mumps and rubella, despite many years of vaccination, retain their epidemiological and social significance at the present time. The aim of the work is to study the safety and immunogenicity. Of the vaccine for the prevention of measles,
I. V. Feldblium, V. V. Romanenko, K. A. Subbotina, M. G. Menshikova, I. A. Okuneva, A. Y. Musikhina, T. E. Snitkovskaya, N. I. Marcovich, A. E. Ershov, D. M. Trofimov   +9 more
doaj   +1 more source

Targeting rubella for elimination

Indian Journal of Public Health, 2012
Rubella is an acute, usually mild viral disease. However, when rubella infection occurs just before conception or during the first 8-10 weeks of gestation, it causes multiple fetal defects in up to 90% of cases, known as Congenital Rubella Syndrome (CRS).
Davendra K Taneja, Pragya Sharma
doaj   +1 more source

ANALYSIS OF THE QUALITY OF NATIONAL VACCINE AGAINST RUBELLA

Вопросы вирусологии, 2018
Until recently Rubella has been a wide spread infection. Thanks to vaccination against rubella, taking part in the global elimination program of “manageable infections” of WHO and adoption of the program “Elimination of measles and rubella in Russian ...
T. N. Unasova, A. S. Binyatova, O. V. Phadeykina, K. A. Sarkisyan, A. A. Movsesyants, G. M. Ignatyev, R. A. Volkova, N. V. Tereshkina, E. S. Sidorenko, T. N. Ilyasova, L. L. Sukhanova   +10 more
doaj   +1 more source

Antibody responses to Hepatitis B and measles-mumps-rubella vaccines in children who received chemotherapy for acute lymphoblastic leukemia

Revista Brasileira de Hematologia e Hemoterapia, 2012
OBJECTIVE: To evaluate viral vaccine antibody levels in children with acute lymphoblastic leukemia after chemotherapy and after vaccine booster doses.
Simone Santana Viana, Gustavo Santos Araujo, Gustavo Baptista de Almeida Faro, Lana Luíza da Cruz-Silva, Carlos André Araújo-Melo, Rosana Cipolotti   +5 more
doaj   +1 more source